Should you buy Bunge stock now?
Yes, the technical signal for Bunge is currently BUY. Bunge trades at $115.32 as of 9/19/2026. The overall technical signal is: Strong Buy. The technical analysis shows the following: MACD is positive (bullish trend) at 1.464 with falling momentum (signal: 2.009); RSI is at 46.4 (neutral zone); the stock is in a short-term downtrend (price below the 20-day average); the analyst price target of $141.78 points to 22.9% upside. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for Bunge stock?
The average analyst price target for Bunge is $141.78. The current price is $115.32, which gives an upside of 22.9%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $127.60 and $155.96.
Is Bunge a dividend stock?
Yes, Bunge is a dividend stock with a dividend yield of 2.42%. The latest dividend was $0.72 per share. The latest ex-dividend date (traded without the dividend) was 8/18/2026. The payout ratio is 35.1%, which is considered sustainable. The next dividend payment is scheduled for 3/2/2027.
When does Bunge pay a dividend in 2026?
Bunge pays its next dividend on 3/2/2027. The latest dividend was $0.72 per share with an ex-dividend date of 8/18/2026. The dividend yield is 2.42%. The payout ratio of 35.1% points to a sustainable dividend with room to grow.
What is the risk of Bunge stock?
Bunge is rated as a stock in the risk category Balanced. the annual standard deviation is 31.7%, which classifies the stock as Balanced.
Is Bunge overvalued?
No, Bunge is considered undervalued based on the analyst price target (22.9% upside). Bunge has the following valuation ratios: a P/E ratio of 25.3 (moderately to highly valued), a P/S ratio of 0.2, a P/B ratio of 1.4. The analyst price target suggests that the stock is undervalued by 22.9%.
Is Bunge overbought?
No, Bunge is not overbought. RSI is at 46.4 (neutral zone). The technical indicators show: RSI is at 46.4 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 2.4% below the 20-day average (short-term downtrend). In addition, MACD is positive, but momentum is falling.
When is the next Bunge earnings report?
Bunge reports its next earnings on November 4, 2026. The stock currently trades at $115.32. With a P/E ratio of 25.3, the market will be watching closely whether earnings meet expectations.
Is Bunge shorted?
Yes, Bunge is shorted with 5.1% of the free float sold short. This is a high level of short selling, which suggests some investors are betting on falling prices. Positive surprises can lead to a moderate short squeeze. Data is updated daily based on official filings with the SEC.
Are insiders buying Bunge stock?
No, insiders are not buying Bunge shares – they are net sellers. Across the last 20 reported transactions, the split is 19 purchases and 1 sales, with a net 2,047,269 $ sold. Active sellers include Dimopoulos Christos. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Bunge a good stock?
Based on our total score, Bunge is rated as a mediocre stock with a total score of 55 out of 100. The stock scores around average on value, quality and momentum – it sits near the median in our database. The score is made up of Value: 74/100, Quality: 31/100, Momentum: 61/100. In addition: analysts see 22.9% upside to the price target; a dividend of 2.42%; technical signal: Strong Buy. Whether Bunge is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Bunge stock?
The outlook for Bunge based on current data: the average analyst price target is $141.78 (+22.9%); the stock is in an uptrend (above SMA50 and SMA200); the next earnings report is due on 11/4/2026, which can move the price; the P/E ratio is 25.3 (moderate). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Bunge stock falling?
Bunge is falling right now. The technical indicators show: the price is 2.4% below the 20-day average; short interest is 5.1% (high – many are betting on a decline); insiders have mostly been buying the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Bunge go?
The average analyst price target for Bunge is $141.78, which corresponds to a potential gain of 22.9% from the current price of $115.32. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Bunge fall?
We lack enough history to give a specific floor for Bunge. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Bunge do?
Bunge Global SA operates as an agribusiness and food company worldwide. It operates through four segments: Soybean Processing and Refining, Softseed Processing and Refining, Other Oilseeds Processing and Refining, and Grain Merchandising and Milling. The Soybean Processing and... The company belongs to the Consumer Defensive sector, more specifically the Farm Products industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Bunge as an investment.
Did Bunge raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Bunge. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Bunge making money or losing money?
Yes, Bunge is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 1.1% — which is modest. The operating margin (profit before interest and taxes) is 4.6%. At a P/E ratio of 25.3, you currently pay 25.3 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Bunge go bankrupt?
The bankruptcy risk of Bunge is rated as low. Altman Z2 (a model for assessing financial distress) is 3.12 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 5 — which is average. Debt relative to equity is 141% (moderate). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Bunge have a lot of debt?
Bunge has moderate debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 141%. For the consumer defensive sector, 100-200% counts as a typical level. Consumer staples deliver predictable earnings — which allows higher debt than in cyclical industries. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can Bunge service its debt? Could struggle to service its debt — the interest coverage ratio (how many times earnings can cover interest payments) is 1.9x, and net debt equals 5.2 years of earnings (EBITDA).